Logo image of S92.DE

SMA SOLAR TECHNOLOGY AG (S92.DE) Stock Fundamental Analysis

FRA:S92 - Deutsche Boerse Ag - DE000A0DJ6J9 - Common Stock - Currency: EUR

18.48  +0.12 (+0.65%)

Fundamental Rating

2

Taking everything into account, S92 scores 2 out of 10 in our fundamental rating. S92 was compared to 54 industry peers in the Semiconductors & Semiconductor Equipment industry. S92 has a bad profitability rating. Also its financial health evaluation is rather negative. S92 does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year S92 has reported negative net income.
S92 had a negative operating cash flow in the past year.
In multiple years S92 reported negative net income over the last 5 years.
In multiple years S92 reported negative operating cash flow during the last 5 years.
S92.DE Yearly Net Income VS EBIT VS OCF VS FCFS92.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

S92 has a worse Return On Assets (-7.64%) than 85.19% of its industry peers.
S92 has a Return On Equity of -21.28%. This is amonst the worse of the industry: S92 underperforms 88.89% of its industry peers.
Industry RankSector Rank
ROA -7.64%
ROE -21.28%
ROIC N/A
ROA(3y)3.77%
ROA(5y)2.36%
ROE(3y)7.88%
ROE(5y)4.87%
ROIC(3y)N/A
ROIC(5y)N/A
S92.DE Yearly ROA, ROE, ROICS92.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

Looking at the Gross Margin, with a value of 16.52%, S92 is doing worse than 94.44% of the companies in the same industry.
In the last couple of years the Gross Margin of S92 has remained more or less at the same level.
S92 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.32%
GM growth 5Y-0.14%
S92.DE Yearly Profit, Operating, Gross MarginsS92.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

More info and screens

2

2. Health

2.1 Basic Checks

S92 does not have a ROIC to compare to the WACC, probably because it is not profitable.
S92 has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for S92 remains at a similar level compared to 5 years ago.
The debt/assets ratio for S92 is higher compared to a year ago.
S92.DE Yearly Shares OutstandingS92.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
S92.DE Yearly Total Debt VS Total AssetsS92.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.77, we must say that S92 is in the distress zone and has some risk of bankruptcy.
S92 has a worse Altman-Z score (1.77) than 79.63% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that S92 is not too dependend on debt financing.
S92 has a better Debt to Equity ratio (0.07) than 79.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 1.77
ROIC/WACCN/A
WACC10.17%
S92.DE Yearly LT Debt VS Equity VS FCFS92.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

S92 has a Current Ratio of 1.52. This is a normal value and indicates that S92 is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of S92 (1.52) is worse than 79.63% of its industry peers.
A Quick Ratio of 0.71 indicates that S92 may have some problems paying its short term obligations.
With a Quick ratio value of 0.71, S92 is not doing good in the industry: 87.04% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 0.71
S92.DE Yearly Current Assets VS Current LiabilitesS92.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

S92 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -152.15%.
The Revenue for S92 has decreased by -45.93% in the past year. This is quite bad
Measured over the past years, S92 shows a quite strong growth in Revenue. The Revenue has been growing by 10.83% on average per year.
EPS 1Y (TTM)-152.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-437.69%
Revenue 1Y (TTM)-45.93%
Revenue growth 3Y15.87%
Revenue growth 5Y10.83%
Sales Q2Q%-17.01%

3.2 Future

S92 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.74% yearly.
The Revenue is expected to grow by 3.14% on average over the next years.
EPS Next Y119.37%
EPS Next 2Y59.13%
EPS Next 3Y38.74%
EPS Next 5YN/A
Revenue Next Year1.77%
Revenue Next 2Y2.66%
Revenue Next 3Y3.14%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
S92.DE Yearly Revenue VS EstimatesS92.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
S92.DE Yearly EPS VS EstimatesS92.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

S92 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 28.15, the valuation of S92 can be described as expensive.
75.93% of the companies in the same industry are cheaper than S92, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of S92 to the average of the S&P500 Index (22.17), we can say S92 is valued slightly more expensively.
Industry RankSector Rank
PE N/A
Fwd PE 28.15
S92.DE Price Earnings VS Forward Price EarningsS92.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
S92.DE Per share dataS92.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

S92's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as S92's earnings are expected to grow with 38.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.13%
EPS Next 3Y38.74%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for S92!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SMA SOLAR TECHNOLOGY AG

FRA:S92 (6/5/2025, 3:05:42 PM)

18.48

+0.12 (+0.65%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-07 2025-08-07/amc
Inst Owners24.55%
Inst Owner ChangeN/A
Ins Owners21.32%
Ins Owner ChangeN/A
Market Cap641.26M
Analysts49.23
Price Target16.9 (-8.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.5
Dividend Growth(5Y)28.99%
DP-14.74%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.93%
Min EPS beat(2)1.06%
Max EPS beat(2)34.8%
EPS beat(4)3
Avg EPS beat(4)25.11%
Min EPS beat(4)-28.28%
Max EPS beat(4)92.88%
EPS beat(8)5
Avg EPS beat(8)15.92%
EPS beat(12)8
Avg EPS beat(12)65.01%
EPS beat(16)11
Avg EPS beat(16)68.42%
Revenue beat(2)1
Avg Revenue beat(2)-6.09%
Min Revenue beat(2)-14.13%
Max Revenue beat(2)1.96%
Revenue beat(4)2
Avg Revenue beat(4)-5.94%
Min Revenue beat(4)-15.17%
Max Revenue beat(4)3.57%
Revenue beat(8)5
Avg Revenue beat(8)-1.46%
Revenue beat(12)7
Avg Revenue beat(12)13.34%
Revenue beat(16)8
Avg Revenue beat(16)15.29%
PT rev (1m)0%
PT rev (3m)8.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-45.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 28.15
P/S 0.42
P/FCF N/A
P/OCF N/A
P/B 1.16
P/tB 1.48
EV/EBITDA N/A
EPS(TTM)-3.39
EYN/A
EPS(NY)0.66
Fwd EY3.55%
FCF(TTM)-5.84
FCFYN/A
OCF(TTM)-3.25
OCFYN/A
SpS44.09
BVpS15.95
TBVpS12.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.64%
ROE -21.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.52%
FCFM N/A
ROA(3y)3.77%
ROA(5y)2.36%
ROE(3y)7.88%
ROE(5y)4.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.32%
GM growth 5Y-0.14%
F-Score1
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 116.67%
Cap/Sales 5.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.52
Quick Ratio 0.71
Altman-Z 1.77
F-Score1
WACC10.17%
ROIC/WACCN/A
Cap/Depr(3y)160.77%
Cap/Depr(5y)137.06%
Cap/Sales(3y)5.37%
Cap/Sales(5y)4.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-152.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-437.69%
EPS Next Y119.37%
EPS Next 2Y59.13%
EPS Next 3Y38.74%
EPS Next 5YN/A
Revenue 1Y (TTM)-45.93%
Revenue growth 3Y15.87%
Revenue growth 5Y10.83%
Sales Q2Q%-17.01%
Revenue Next Year1.77%
Revenue Next 2Y2.66%
Revenue Next 3Y3.14%
Revenue Next 5YN/A
EBIT growth 1Y-129.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year195.9%
EBIT Next 3Y56.74%
EBIT Next 5YN/A
FCF growth 1Y-459.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-180.09%
OCF growth 3YN/A
OCF growth 5YN/A